| | | | | | | | | | |
|
|
| Dockets Entered
On April 21, 2004
Table of Contents
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
| 1977N-0094
|
| OTC Internal Analgesic, Antipyretic & Antirheumatic Products
|
|
|
| 1979P-0055
|
| Avi Laserlumia
|
|
|
| 1992N-0297
|
| Prescription Drug Marketing Act of 1987, Drug Amds of 1992
|
|
|
| 1995N-0304
|
| Ephedrine Alkaloids: Reports of Adverse Events; Availability
|
|
|
| 1997N-0497
|
| Allogeneic Peripheral and Placental/ Umbilical Cord Blood
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
| 2000P-0586
|
| Amend Pt 133.3 re:Milk and Nonfat Milk for use in Standardiz
|
|
|
| 2000P-0685
|
| Revise of Yogurt Standards
|
|
|
| 2000P-1322
|
| Food Labeling and Allergen Contamination Control
|
|
|
| 2001P-0075
|
| Switch Status of Emergency Contraceptives from Rx to OTC
|
|
|
| 2003D-0137
|
| Surgical Masks - Premarket Notification [510(k)] Submissions; Draft Guidance for Industry and FDA; Availability
|
|
|
| 2003N-0400
|
| Control of Communicable Diseases; Restrictions on African Rodents, Prairie Dogs, and Certain Other Animals
|
|
|
| 2003P-0132
|
| Part 135 FDA regulations standard of identity frozen dessert
|
|
|
| 2003P-0551
|
| Citalopram Hydrobromide Capsules
|
|
|
| 2003P-0555
|
| Maintain the Electroconvulsive Therapy Device in Class III for All Indications
|
|
|
| 2004D-0042
|
| Guidances for Industry on Improving Direct-to-Consumer Advertising for Medical Products
|
|
|
| 2004P-0004
|
| Correct of FDA's advice for women who are pregnant, or might become pregnant, and nursing mother, about avoiding harm to your baby or young child from mercury in fish and shellfish
|
|
|
| 2004P-0131
|
| ANDA Suitability for Tofin (tobramycin for Inhalation)
|
|
|
| 1977N-0094
|
| OTC Internal Analgesic, Antipyretic & Antirheumatic Products
|
|
|
| SUP
51
Attachment
|
| Istituto Di Ricerche Farmacologiche (Mario Negri)
|
| Vol #:
|
| 235
|
|
|
| 1979P-0055
|
| Avi Laserlumia
|
|
|
| EXP
8
|
| Audio Visual Imagineering, Inc.
|
| Vol #:
|
| 1
|
|
|
| 1992N-0297
|
| Prescription Drug Marketing Act of 1987, Drug Amds of 1992
|
|
|
| C
129
|
| America's Blood Centers (ABC)
|
| Vol #:
|
| 8
|
|
|
| 1995N-0304
|
| Ephedrine Alkaloids: Reports of Adverse Events; Availability
|
|
|
| SUP
4
References
|
| Nutraceutical Corporation
|
| Vol #:
|
| 396
|
|
|
| 1997N-0497
|
| Allogeneic Peripheral and Placental/ Umbilical Cord Blood
|
|
|
| SUP
2
Attachment
|
| Foundation for the Accreditation of Cellular Therapy (FACT)
|
| Vol #:
|
| 6
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
| LET
13708
|
| Neway's, Inc.
|
| Vol #:
|
| 116
|
|
|
| LET
13709
|
| Neway's, Inc.
|
| Vol #:
|
| 116
|
|
|
| LET
13710
|
| Neway's, Inc.
|
| Vol #:
|
| 116
|
|
| | | | | | | | |
|
|
| C 104
|
| J. Fox
|
| Vol #:
|
| 37
|
|
|
| C 105
|
| C. Smith
|
| Vol #:
|
| 37
|
|
|
| 2003P-0132
|
| Part 135 FDA regulations standard of identity frozen dessert
|
|
|
| C 7
|
| M. Julian
|
| Vol #:
|
| 1
|
|
|
| 2003P-0551
|
| Citalopram Hydrobromide Capsules
|
|
|
| LET
1
|
| HFD-600 to Frommer Lawrence & Haug, LLP
|
| Vol #:
|
| 1
|
|
|
| 2003P-0555
|
| Maintain the Electroconvulsive Therapy Device in Class III for All Indications
|
|
|
| C 7
|
| A. Beard
|
| Vol #:
|
| 1
|
|
|
| SUP
1
|
| Depression and Bipolar Support Alliance
|
| Vol #:
|
| 2
|
|
|
| 2004D-0042
|
| Guidances for Industry on Improving Direct-to-Consumer Advertising for Medical Products
|
|
|
| SUP
1
Attachment
|
| Dana-Farber Cancer Institute
|
| Vol #:
|
| 1
|
|
|
| 2004P-0004
|
| Correct of FDA's advice for women who are pregnant, or might become pregnant, and nursing mother, about avoiding harm to your baby or young child from mercury in fish and shellfish
|
|
|
|
|
|
| LET
2
|
| HFS-6 to Environmental Working Group
|
| Vol #:
|
| 1
|
|
|
| 2004P-0131
|
| ANDA Suitability for Tofin (tobramycin for Inhalation)
|
|
|
| C
1
|
| Chiron Corporation (Chiron)
|
| Vol #:
|
| 1
|
|